Predicting early esophageal cancer return after surgery
Part of Cancer, Digestive system clinical trials.
This trial uses stored tumor tissue to try to predict if esophageal cancer will come back early after surgery. It is for people who had surgery only (no chemo or radiation) and have been followed for at least 2 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a type of esophageal cancer called squamous cell carcinoma.
- You had surgery to remove the esophagus and lymph nodes, but no chemotherapy or radiation before or after.
- A tissue sample from your tumor is available for testing.
- Your doctor has followed you for at least 2 years after surgery.
- You do not have any other cancers besides the esophageal cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a biopsy taken before chemotherapy can help predict how well the treatment will work for people with esophageal squamous cell carcinoma. It aims to improve future treatment decisions.
This study looks back at past patients’ medical and pathology records from esophageal cancer surgeries. It may help improve how doctors understand which advanced tumors should be treated, by reviewing outcomes in specific tumor stages.
This trial uses a blood test to track genetic changes in esophageal cancer over time. It aims to see if these changes can show how well treatment is working.
This trial uses a blood test to find tiny bits of tumor DNA after surgery. If the test is positive, you may receive additional therapy to lower the risk of cancer coming back.
This study follows people who had early-stage esophageal cancer removed with a minimally invasive procedure (ESD) to see how they do over time. It aims to understand how often the cancer comes back or spreads, and what factors might affect that.
This trial looks at whether a personalized blood test can detect cancer returning after surgery for esophageal cancer. It tests people who had chemoradiotherapy before surgery and still had some cancer remaining in the removed tissue. The goal is to use the blood test to catch any remaining or returning cancer early.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.